| First Author | Mihira H | Year | 2012 |
| Journal | J Biochem | Volume | 151 |
| Issue | 2 | Pages | 145-56 |
| PubMed ID | 21984612 | Mgi Jnum | J:224732 |
| Mgi Id | MGI:5688835 | Doi | 10.1093/jb/mvr121 |
| Citation | Mihira H, et al. (2012) TGF-beta-induced mesenchymal transition of MS-1 endothelial cells requires Smad-dependent cooperative activation of Rho signals and MRTF-A. J Biochem 151(2):145-56 |
| abstractText | Endothelial-mesenchymal transition (EndMT) plays important roles in various physiological and pathological processes. While signals mediated by transforming growth factor (TGF)-beta have been implicated in EndMT, the molecular mechanisms underlying it remain to be fully elucidated. Here, we examined the effects of TGF-beta signals on the EndMT of mouse pancreatic microvascular endothelial cells (MS-1). By addition of TGF-beta2, MS-1 cells underwent mesenchymal transition characterized by re-organization of actin stress fibre and increased expression of various mesenchymal markers such as alpha-smooth muscle actin (alpha-SMA) through activation of Rho signals. Whereas activation of Rho signals via TGF-beta-induced non-Smad signals has been implicated in epithelial-mesenchymal transition (EMT), we found that Arhgef5, a guanine nucleotide exchange factor, is induced by Smad signals and contributes to the TGF-beta2-induced alpha-SMA expression in MS-1 cells. We also found that TGF-beta2 induces the expression of myocardin-related transcription factor-A (MRTF-A) in a Smad-dependent fashion and its nuclear accumulation in MS-1 cells and that MRTF-A is required and sufficient for TGF-beta2-induced alpha-SMA expression. These results indicate that activation of Smad signals by TGF-beta2 have dual effects on the activation of Rho signals and MRTF-A leading to the mesenchymal transition of MS-1 endothelial cells. |
